speb/financial-data huggingface dataset:
Financial ratios for CNTA — annual report dated 2022-12-31
Total revenue: 0
Operating income: -253353012.04819277
Net income: -260490361.44578314
Capital expenditures: 1369879.5180722892
Operating cash flow: -241621686.74698797
Depreciation & amortization: 157831.32530120484
Net tangible assets: 405022891.5662651
Owner earnings: -261702409.63855422
Return on net tangible assets (%): -64.61422677284341
Buffett classification: The Gruesome
Stock price: 3.1
Shares outstanding: 154731309
Book value: 405022891.5662651
P/B ratio: 1.1842961666810443
Market cap (USD): 479667057.90000004
Debt to equity: 0.20763366045054718
Current ratio: 11.418096927330584
Quick ratio: 11.418096927330584
Interest coverage ratio: -28.89693555036416
Free cash flow (dilution-adjusted): -273069879.5180723
Buyback yield (%): 0
Retained earnings: -725132530.120482
Receivables turnover: 0
Capitalized R&D asset: 186846987.95180723
ROCI (R&D-adjusted, %): -19.05248236051798
Rule of 40 score: 0
Financial ratios for CNTA — annual report dated 2023-12-31
Total revenue: 8674683.544303797
Operating income: -216813924.0506329
Net income: -191246835.44303796
Capital expenditures: 213924.05063291139
Operating cash flow: -202964556.9620253
Depreciation & amortization: 1025316.4556962025
Net tangible assets: 299043037.9746835
Owner earnings: -190435443.0379747
Return on net tangible assets (%): -63.68161731091584
Buffett classification: The Gruesome
Stock price: 7.96
Shares outstanding: 154731309
Book value: 299043037.9746835
P/B ratio: 4.118675452141007
Market cap (USD): 1231661219.64
Debt to equity: 0.3580535378676284
Current ratio: 8.000304684524565
Quick ratio: 8.000304684524565
Interest coverage ratio: -17.29083383807793
COGS to revenue (%): 0
R&D to revenue (%): 1815.3363490442143
SG&A to revenue (%): 784.0507806799941
Free cash flow (dilution-adjusted): -240383544.30379745
Buyback yield (%): 0
Retained earnings: -953094936.7088608
Receivables turnover: 0.17505364258710535
Capitalized R&D asset: 282662165.47201467
ROCI (R&D-adjusted, %): -25.27718583117311
FCF margin (%): -2771.0929519918286
Rule of 40 score: -2771.0929519918286
Financial ratios for CNTA — quarterly report dated 2024-09-30
Capital expenditures: 45333.333333333336
Buffett classification: The Gruesome
Stock price: 15.99
Shares outstanding: 154731309
Market cap (USD): 2474153630.91
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CNTA — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 16.75
Shares outstanding: 154731309
Market cap (USD): 2591749425.75
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CNTA — annual report dated 2024-12-31
Total revenue: 0
Operating income: -251318750
Net income: -294696250
Capital expenditures: 42500
Operating cash flow: -177568750
Depreciation & amortization: 1177500
Net tangible assets: 501931250
Owner earnings: -293561250
Return on net tangible assets (%): -58.48634648669514
Buffett classification: The Gruesome
Stock price: 16.75
Shares outstanding: 154731309
Book value: 501931250
P/B ratio: 5.1635546217734
Market cap (USD): 2591749425.75
Debt to equity: 0.29343660112814257
Current ratio: 9.248749956895065
Quick ratio: 9.248749956895065
Interest coverage ratio: -19.926164519326065
Free cash flow (dilution-adjusted): -219543750
Buyback yield (%): 0
Retained earnings: -1235877500
Receivables turnover: 0
Capitalized R&D asset: 354972543.9987799
ROCI (R&D-adjusted, %): -24.005570317394078
Revenue growth (%): -100
Rule of 40 score: -100
Financial ratios for CNTA — quarterly report dated 2025-03-31
Total revenue: 19480519.48051948
Operating income: -39970129.87012987
Net income: -33941558.44155844
Capital expenditures: 0
Operating cash flow: -74345454.54545455
Depreciation & amortization: 281818.1818181818
Net tangible assets: 501619480.5194805
Owner earnings: -33659740.25974026
Return on net tangible assets (%): -6.710213930464186
Buffett classification: The Gruesome
Stock price: 14.38
Shares outstanding: 154731309
Book value: 501619480.5194805
P/B ratio: 4.435705369966369
Market cap (USD): 2225036223.42
Debt to equity: 0.3054936349020187
Current ratio: 14.367325014461615
Quick ratio: 14.367325014461615
Interest coverage ratio: -10.697601668404587
COGS to revenue (%): 0
R&D to revenue (%): 222.9533333333333
SG&A to revenue (%): 82.22666666666667
Free cash flow (dilution-adjusted): -84583116.88311689
Buyback yield (%): 0
Retained earnings: -1317970129.8701298
Receivables turnover: 0.284608378870674
Capitalized R&D asset: 43432467.53246753
ROCI (R&D-adjusted, %): -1.5792008480330275
FCF margin (%): -434.1933333333333
Rule of 40 score: -434.1933333333333
Financial ratios for CNTA — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -74867123.28767124
Net income: -68963013.69863014
Capital expenditures: 0
Operating cash flow: -30756164.383561645
Depreciation & amortization: 309589.0410958904
Net tangible assets: 472491780.82191783
Owner earnings: -68653424.65753424
Return on net tangible assets (%): -14.530078076301969
Buffett classification: The Gruesome
Stock price: 13.14
Shares outstanding: 154731309
Book value: 472491780.8219178
P/B ratio: 4.303078874140885
Market cap (USD): 2033169400.26
Debt to equity: 0.3425180984521004
Current ratio: 10.115275813295616
Quick ratio: 10.115275813295616
Interest coverage ratio: -18.950416088765603
Free cash flow (dilution-adjusted): -41817808.21917808
Buyback yield (%): 0
Retained earnings: -1459150684.9315069
Receivables turnover: 0
Capitalized R&D asset: 87649068.3152464
ROCI (R&D-adjusted, %): -6.97689847916106
Revenue growth (%): -100
Rule of 40 score: -100
Financial ratios for CNTA — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -72689189.1891892
Net income: -74177027.02702703
Capital expenditures: 316216.2162162162
Operating cash flow: -78800000
Depreciation & amortization: 320270.2702702703
Net tangible assets: 407532432.4324324
Owner earnings: -74172972.97297297
Return on net tangible assets (%): -18.2005080013529
Buffett classification: The Gruesome
Stock price: 24.25
Shares outstanding: 154731309
Book value: 407532432.4324324
P/B ratio: 9.207204003014187
Market cap (USD): 3752234243.25
Debt to equity: 0.3921392427729181
Current ratio: 10.565036741982007
Quick ratio: 10.565036741982007
Interest coverage ratio: -18.612456747404845
Free cash flow (dilution-adjusted): -88837837.83783785
Buyback yield (%): 0
Retained earnings: -1513609459.4594595
Receivables turnover: 0
Capitalized R&D asset: 109726971.59782091
ROCI (R&D-adjusted, %): -10.239668550910624
Rule of 40 score: 0
Financial ratios for CNTA — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -92529729.72972973
Net income: -89409459.45945945
Capital expenditures: 14864.864864864865
Operating cash flow: -75414864.86486487
Depreciation & amortization: 325675.6756756757
Net tangible assets: 711977027.027027
Owner earnings: -89098648.64864865
Return on net tangible assets (%): -12.514258924995683
Buffett classification: The Gruesome
Stock price: 25.01
Shares outstanding: 154731309
Book value: 711977027.0270271
P/B ratio: 5.435329921035638
Market cap (USD): 3869830038.09
Debt to equity: 0.2246902895060006
Current ratio: 8.568184464888786
Quick ratio: 8.568184464888786
Interest coverage ratio: -24.384615384615383
Free cash flow (dilution-adjusted): -86154054.05405405
Buyback yield (%): 0
Retained earnings: -1603018918.9189188
Receivables turnover: 0
Capitalized R&D asset: 130570206.40503518
ROCI (R&D-adjusted, %): -8.155959207242438
Rule of 40 score: 0
Financial ratios for CNTA — annual report dated 2025-12-31
Total revenue: 20270270.27027027
Operating income: -280664864.8648649
Net income: -266935135.13513514
Capital expenditures: 501351.35135135136
Operating cash flow: -261914864.86486486
Depreciation & amortization: 1244594.5945945946
Net tangible assets: 711977027.027027
Owner earnings: -266191891.8918919
Return on net tangible assets (%): -37.38770799999241
Buffett classification: The Gruesome
Stock price: 25.01
Shares outstanding: 154731309
Book value: 711977027.0270271
P/B ratio: 5.435329921035638
Market cap (USD): 3869830038.09
Debt to equity: 0.2246902895060006
Current ratio: 8.568184464888786
Quick ratio: 8.568184464888786
Interest coverage ratio: -18.124792739331532
COGS to revenue (%): 0
R&D to revenue (%): 1148.16
SG&A to revenue (%): 336.4533333333334
Free cash flow (dilution-adjusted): -304256756.7567567
Buyback yield (%): 0
Retained earnings: -1603018918.9189188
Receivables turnover: 0.24858719610215274
Capitalized R&D asset: 410531130.7047554
ROCI (R&D-adjusted, %): -18.774125427288247
FCF margin (%): -1501
Rule of 40 score: -1501
Financial ratios for DERM — annual report dated 2021-12-31
Capital expenditures: 10000000
Buffett classification: The Gruesome
Stock price: 5.38
Shares outstanding: 21534547
Market cap (USD): 115855862.86
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DERM — annual report dated 2022-12-31
Total revenue: 73669000
Gross profit: 42894000
Operating income: -27517000
Net income: -29628000
Capital expenditures: 20000000
Operating cash flow: -13534000
Depreciation & amortization: 4365000
Net tangible assets: -10215000
Owner earnings: -45263000
Buffett classification: The Gruesome
Stock price: 1.92
Shares outstanding: 21534547
Book value: 16982000
P/B ratio: 2.4347150064774468
Market cap (USD): 41346330.24
Debt to equity: 1.3523142150512306
Current ratio: 1.1623024898252334
Quick ratio: 0.950442901604022
Interest coverage ratio: -13.629024269440317
COGS to revenue (%): 41.774694919165455
R&D to revenue (%): 14.85428063364509
SG&A to revenue (%): 80.72323501065577
Free cash flow (dilution-adjusted): -37959000
Buyback yield (%): 0
Retained earnings: -68502000
Inventory turnover: 2.1735292040398333
Receivables turnover: 2.611634997163925
Capitalized R&D asset: 10943000
ROCI (R&D-adjusted, %): -41.04172163476826
FCF margin (%): -51.52642224001954
Rule of 40 score: -51.52642224001954
Financial ratios for DERM — annual report dated 2023-12-31
Total revenue: 79181000
Gross profit: 56288000
Operating income: 1070000
Net income: -3853000
Capital expenditures: 5000000
Operating cash flow: 5240000
Depreciation & amortization: 3855000
Net tangible assets: 63000
Owner earnings: -4998000
Return on net tangible assets (%): -7933.333333333333
Capex to operating income (%): 467.2897196261682
Buffett classification: The Gruesome
Stock price: 5.76
Shares outstanding: 21534547
Book value: 20350000
P/B ratio: 6.095282099262899
Market cap (USD): 124038990.72
Debt to equity: 0.7238329238329239
Current ratio: 1.3484045094105284
Quick ratio: 1.104638387312506
Interest coverage ratio: 0.6301531213191991
COGS to revenue (%): 28.912239047246185
R&D to revenue (%): 9.523749384321995
SG&A to revenue (%): 55.455222843864064
Free cash flow (dilution-adjusted): -2366000
Buyback yield (%): 0
Retained earnings: -72355000
Inventory turnover: 2.2430922986478543
Receivables turnover: 5.201747470765997
Capitalized R&D asset: 14872810
ROCI (R&D-adjusted, %): 4.913700009420879
Rosenberg metric: 1.223978799232386
FCF margin (%): -2.9880905772849546
Revenue growth (%): 7.482115951078473
Rule of 40 score: 4.4940253737935185
Financial ratios for DERM — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.65
Shares outstanding: 21534547
Market cap (USD): 121670190.55000001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DERM — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.91
Shares outstanding: 21534547
Market cap (USD): 84200078.77
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DERM — annual report dated 2024-12-31
Total revenue: 56134000
Gross profit: 35255000
Operating income: -18230000
Net income: -14672000
Capital expenditures: 15000000
Operating cash flow: -9127000
Depreciation & amortization: 3515000
Net tangible assets: -11794000
Owner earnings: -26157000
Buffett classification: The Gruesome
Stock price: 3.91
Shares outstanding: 21534547
Book value: 20069000
P/B ratio: 4.195529362200409
Market cap (USD): 84200078.77
Debt to equity: 1.249688574418257
Current ratio: 1.3696943852167733
Quick ratio: 0.9594314143567875
Interest coverage ratio: -6.7518518518518515
COGS to revenue (%): 37.19492642605195
R&D to revenue (%): 17.55976769872092
SG&A to revenue (%): 71.62147717960595
Free cash flow (dilution-adjusted): -30225000
Buyback yield (%): 0
Retained earnings: -87027000
Inventory turnover: 1.4468158824752269
Receivables turnover: 5.486658195679797
Capitalized R&D asset: 18520660
ROCI (R&D-adjusted, %): -28.024746070952617
Rosenberg metric: -2.7891526322768865
FCF margin (%): -53.844372394627136
Revenue growth (%): -29.106730149909698
Rule of 40 score: -82.95110254453684
Financial ratios for DERM — quarterly report dated 2025-03-31
Total revenue: 13139000
Gross profit: 8349000
Operating income: -3324000
Net income: -4073000
Capital expenditures: 0
Operating cash flow: -2832000
Depreciation & amortization: 1086000
Net tangible assets: -9257000
Owner earnings: -2987000
Buffett classification: The Gruesome
Stock price: 5.9
Shares outstanding: 21534547
Book value: 21541000
P/B ratio: 5.898232547235504
Market cap (USD): 127053827.30000001
Debt to equity: 1.1683301610881576
Current ratio: 1.3422007856396996
Quick ratio: 1.0315250360499228
Interest coverage ratio: -3.7306397306397305
COGS to revenue (%): 36.45635132049623
R&D to revenue (%): 0.2968262424842073
SG&A to revenue (%): 80.43991171322018
Free cash flow (dilution-adjusted): -4155000
Buyback yield (%): 0
Retained earnings: -91100000
Inventory turnover: 0.38332266325224074
Receivables turnover: 0.7289320388349515
Capitalized R&D asset: 39000
ROCI (R&D-adjusted, %): -7.3650595145045665
FCF margin (%): -31.62341121850978
Rule of 40 score: -31.62341121850978
Financial ratios for DERM — quarterly report dated 2025-06-30
Total revenue: 15009000
Gross profit: 10070000
Operating income: -2876000
Net income: -3796000
Capital expenditures: 0
Operating cash flow: -942000
Depreciation & amortization: 1086000
Net tangible assets: -10488000
Owner earnings: -2710000
Buffett classification: The Gruesome
Stock price: 7.18
Shares outstanding: 21534547
Book value: 19246000
P/B ratio: 8.033775717551698
Market cap (USD): 154618047.46
Debt to equity: 1.3133638158578407
Current ratio: 1.2664706899533114
Quick ratio: 0.9489884143178281
Interest coverage ratio: -3.069370330843116
COGS to revenue (%): 32.90692251315877
R&D to revenue (%): 0
SG&A to revenue (%): 79.16583383303352
Free cash flow (dilution-adjusted): -2278000
Buyback yield (%): 0
Retained earnings: -94896000
Inventory turnover: 0.3842981637099284
Receivables turnover: 0.959409358220404
Capitalized R&D asset: 26130
ROCI (R&D-adjusted, %): -7.097734252869496
Rosenberg metric: 44.12820512820513
FCF margin (%): -15.177560130588313
Revenue growth (%): 14.232437780653019
Rule of 40 score: -0.9451223499352945
Financial ratios for DERM — quarterly report dated 2025-09-30
Total revenue: 17631000
Gross profit: 11876000
Operating income: -1529000
Net income: -2315000
Capital expenditures: 0
Operating cash flow: -2383000
Depreciation & amortization: 1086000
Net tangible assets: -2772000
Owner earnings: -1229000
Buffett classification: The Gruesome
Stock price: 7.12
Shares outstanding: 21534547
Book value: 25898000
P/B ratio: 5.92037897289366
Market cap (USD): 153325974.64000002
Debt to equity: 0.9769480268746621
Current ratio: 1.4197910109530405
Quick ratio: 1.1222208233664863
Interest coverage ratio: -1.631803628601921
COGS to revenue (%): 32.64137031365209
R&D to revenue (%): 1.627814644659974
SG&A to revenue (%): 68.36821507571891
Free cash flow (dilution-adjusted): -4237000
Buyback yield (%): 0
Retained earnings: -97211000
Inventory turnover: 0.4869690302927737
Receivables turnover: 0.9804259578490797
Capitalized R&D asset: 299870
ROCI (R&D-adjusted, %): -2.950608402782223
FCF margin (%): -24.031535363847766
Revenue growth (%): 17.469518289026585
Rule of 40 score: -6.562017074821181
Financial ratios for DERM — annual report dated 2025-12-31
Total revenue: 61858000
Gross profit: 40934000
Operating income: -8172000
Net income: -11431000
Capital expenditures: 0
Operating cash flow: -12441000
Depreciation & amortization: 4346000
Net tangible assets: 4247000
Owner earnings: -7085000
Return on net tangible assets (%): -166.82364021662352
Buffett classification: The Gruesome
Stock price: 7.71
Shares outstanding: 21534547
Book value: 31852000
P/B ratio: 5.2125881379505214
Market cap (USD): 166031357.37
Debt to equity: 0.7973125706392064
Current ratio: 1.7860424122643022
Quick ratio: 1.5290048608514502
Interest coverage ratio: -2.2098431584640346
COGS to revenue (%): 33.825859225969154
R&D to revenue (%): 0.7759707717675968
SG&A to revenue (%): 71.72556500371819
Free cash flow (dilution-adjusted): -18729000
Buyback yield (%): 0
Retained earnings: -98458000
Inventory turnover: 2.1741479634247716
Receivables turnover: 2.0769566531242654
Capitalized R&D asset: 9572720
ROCI (R&D-adjusted, %): -20.460717361124015
Rosenberg metric: 0.576138784620067
FCF margin (%): -30.277409550906913
Revenue growth (%): 10.197028538853457
Rule of 40 score: -20.080381012053458
Financial ratios for DERM — quarterly report dated 2025-12-31
Total revenue: 16079000
Gross profit: 10639000
Operating income: -443000
Net income: -1247000
Capital expenditures: 0
Operating cash flow: -6284000
Depreciation & amortization: 1088000
Net tangible assets: 4247000
Owner earnings: -159000
Return on net tangible assets (%): -3.7438191664704497
Buffett classification: The Gruesome
Stock price: 7.71
Shares outstanding: 21534547
Book value: 31852000
P/B ratio: 5.2125881379505214
Market cap (USD): 166031357.37
Debt to equity: 0.7973125706392064
Current ratio: 1.7860424122643022
Quick ratio: 1.5290048608514502
Interest coverage ratio: -0.47481243301178994
COGS to revenue (%): 33.83294981031158
R&D to revenue (%): 0.957771005659556
SG&A to revenue (%): 61.340879407923374
Free cash flow (dilution-adjusted): -8059000
Buyback yield (%): 0
Retained earnings: -98458000
Inventory turnover: 0.5652535328345802
Receivables turnover: 0.5398717389114596
Capitalized R&D asset: 346290
ROCI (R&D-adjusted, %): -0.7583493656390163
Rosenberg metric: -4.310104529616725
FCF margin (%): -50.121276198768584
Revenue growth (%): -8.802677102830241
Rule of 40 score: -58.92395330159883
Financial ratios for DIVISLAB.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 56.543056837663194
Shares outstanding: 265468580
Market cap (USD): 15010405007.55374
Buyback yield (%): 0
Retained earnings: 1317268890.9402611
Capitalized R&D asset: 2675722.009758671
Rule of 40 score: 0
Financial ratios for DIVISLAB.NS — annual report dated 2023-03-31
Total revenue: 933617539.585871
Gross profit: 546528623.6297199
Operating income: 246894031.66869673
Net income: 222168087.69792938
Capital expenditures: 57612667.47868454
Operating cash flow: 299512789.2813642
Depreciation & amortization: 41778319.12302071
Net tangible assets: 1554445797.8075519
Owner earnings: 206333739.34226555
Return on net tangible assets (%): 13.27378153894374
Capex to operating income (%): 23.334977799703996
Buffett classification: The Great
Stock price: 33.75188794153472
P/E ratio: 40.33012057222587
Shares outstanding: 265468580
Book value: 1555054811.2058465
P/B ratio: 5.761897072432052
Market cap (USD): 8960065764.158344
Debt to equity: 0.0003133077465340331
Current ratio: 8.457765667574932
Quick ratio: 5.732970027247956
Effective tax rate (%): 23.005487547488393
COGS to revenue (%): 41.46118721461187
R&D to revenue (%): 0.3913894324853229
SG&A to revenue (%): 3.131115459882583
Free cash flow (dilution-adjusted): 241900121.8026797
Buyback yield (%): 0
Retained earnings: 1334835566.3824606
Inventory turnover: 1.0593333333333332
Receivables turnover: 4.274958170663693
Capitalized R&D asset: 5446814.136306885
ROCI (R&D-adjusted, %): 15.241129554759631
FCF margin (%): 25.90998043052838
Rule of 40 score: 25.90998043052838
Financial ratios for DIVISLAB.NS — annual report dated 2024-03-31
Total revenue: 934884278.6904905
Gross profit: 542870847.82348
Operating income: 219690610.38493824
Net income: 191869528.72047007
Capital expenditures: 120278210.81664468
Operating cash flow: 151217172.32282048
Depreciation & amortization: 45329176.16021106
Net tangible assets: 1626933685.094136
Owner earnings: 116920494.06403644
Return on net tangible assets (%): 7.186555612884203
Capex to operating income (%): 54.748908296943235
Buffett classification: The Good
Stock price: 40.89203454894434
P/E ratio: 56.57777145444691
Shares outstanding: 265468580
Book value: 1627413358.9159372
P/B ratio: 6.670432121959698
Market cap (USD): 10855550345.019194
Debt to equity: 0.0002210596124088129
Current ratio: 7.570422535211268
Quick ratio: 5.079029733959311
Effective tax rate (%): 26.028663892741566
Interest coverage ratio: 610.6666666666666
COGS to revenue (%): 41.93175987685993
R&D to revenue (%): 0.44894817855310415
SG&A to revenue (%): 2.7578245253976394
Free cash flow (dilution-adjusted): 30938961.5061758
Buyback yield (%): 0
Retained earnings: 1413358915.9371626
Inventory turnover: 1.0266959798994975
Receivables turnover: 3.6159554730983303
Capitalized R&D asset: 7528368.065125589
ROCI (R&D-adjusted, %): 12.892087521627413
Rosenberg metric: -1.001011312307637
FCF margin (%): 3.309389430477168
Revenue growth (%): 0.13568073123191282
Rule of 40 score: 3.445070161709081
Financial ratios for DIVISLAB.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 1637959866.2207358
Buffett classification: The Gruesome
Stock price: 64.72384137601529
Shares outstanding: 265468580
Book value: 1638437649.3072147
P/B ratio: 10.48690883629365
Market cap (USD): 17182146262.236023
Debt to equity: 0.0005832179047896769
Current ratio: 7.235476374903175
Quick ratio: 4.799380325329202
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DIVISLAB.NS — quarterly report dated 2024-12-31
Total revenue: 270311225.08450866
Gross profit: 162839491.782259
Operating income: 75067024.12868632
Net income: 68656020.51521155
Capital expenditures: 0
Depreciation & amortization: 11539806.504254574
Owner earnings: 80195827.01946613
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 70.76768854178808
P/E ratio: 68.40841358882852
Shares outstanding: 265468580
Market cap (USD): 18786597787.07075
Effective tax rate (%): 18.870523415977964
COGS to revenue (%): 39.758516601983615
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DIVISLAB.NS — annual report dated 2025-03-31
Total revenue: 1090133270.9843347
Gross profit: 637713350.4793079
Operating income: 300561140.9866729
Net income: 256137479.54173484
Capital expenditures: 168108487.2574234
Operating cash flow: 193242927.28548047
Depreciation & amortization: 46995557.6338555
Net tangible assets: 1749473930.324994
Owner earnings: 135024549.91816694
Return on net tangible assets (%): 7.718008686936184
Capex to operating income (%): 55.931544146246594
Buffett classification: The Good
Stock price: 67.09382658419887
P/E ratio: 69.53805785057459
Shares outstanding: 265468580
Book value: 1749941547.813888
P/B ratio: 10.178227319834921
Market cap (USD): 17811302870.073524
Debt to equity: 0.00026721891909947226
Current ratio: 6.942837465564738
Quick ratio: 4.714187327823691
Effective tax rate (%): 24.862825788751714
Interest coverage ratio: 1285.5
COGS to revenue (%): 41.50134048257373
R&D to revenue (%): 0.28954423592493295
SG&A to revenue (%): 2.991957104557641
Free cash flow (dilution-adjusted): 25134440.028057046
Buyback yield (%): 0
Retained earnings: 1566518587.7951834
Inventory turnover: 1.195920889987639
Receivables turnover: 3.41450018308312
Capitalized R&D asset: 7174352.35896809
ROCI (R&D-adjusted, %): 16.514719320626693
Rosenberg metric: 22.596903704198535
FCF margin (%): 2.3056300268096517
Revenue growth (%): 16.606225586690186
Rule of 40 score: 18.91185561349984
Financial ratios for DIVISLAB.NS — quarterly report dated 2025-03-31
Total revenue: 302197802.1978022
Gross profit: 187514613.04652792
Operating income: 91068505.96212298
Net income: 77390694.411971
Capital expenditures: 0
Depreciation & amortization: 12508767.827916764
Net tangible assets: 1749473930.324994
Owner earnings: 89899462.23988777
Return on net tangible assets (%): 5.138656866020716
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 67.09382658419887
P/E ratio: 57.53696554026017
Shares outstanding: 265468580
Book value: 1749941547.813888
P/B ratio: 10.178227319834921
Market cap (USD): 17811302870.073524
Debt to equity: 0.00026721891909947226
Current ratio: 6.942837465564738
Quick ratio: 4.714187327823691
Effective tax rate (%): 23.379629629629626
Interest coverage ratio: 779
COGS to revenue (%): 37.949709864603484
Buyback yield (%): 0
Retained earnings: 1566518587.7951834
Inventory turnover: 0.3031520395550062
Receivables turnover: 0.9465397290369829
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.032299741602068
Revenue growth (%): 11.796246013581078
Rule of 40 score: 11.796246013581078
Financial ratios for DIVISLAB.NS — quarterly report dated 2025-06-30
Total revenue: 282003276.38661367
Gross profit: 170138076.29300258
Operating income: 72197519.30727826
Net income: 63772525.15796865
Capital expenditures: 0
Depreciation & amortization: 13105546.45448163
Owner earnings: 76878071.61245027
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 79.31933068102036
P/E ratio: 100.35681224417459
Shares outstanding: 265468580
Market cap (USD): 21056790082.440907
Effective tax rate (%): 25.64802182810368
Interest coverage ratio: 205.66666666666666
COGS to revenue (%): 39.66804979253112
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -6.682552177520565
Rule of 40 score: -6.682552177520565
Financial ratios for DIVISLAB.NS — quarterly report dated 2025-12-31
Total revenue: 290074635.1787903
Gross profit: 184805614.34777766
Operating income: 85997549.29263674
Net income: 64943745.12643422
Capital expenditures: 0
Depreciation & amortization: 13144703.130221678
Owner earnings: 78088448.2566559
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 71.20975827113736
P/E ratio: 68.80094637137827
Shares outstanding: 265468580
Market cap (USD): 18903953410.38209
Effective tax rate (%): 25.256410256410255
Interest coverage ratio: 128.66666666666666
COGS to revenue (%): 36.29032258064516
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 2.8621507152672714
Rule of 40 score: 2.8621507152672714
Financial ratios for DLTH — annual report dated 2022-01-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 15.08
Shares outstanding: 34637871
Market cap (USD): 522339094.68
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DLTH — annual report dated 2023-01-31
Total revenue: 653307000
Gross profit: 343435000
Operating income: 6231000
Net income: 2304000
Capital expenditures: 27037000
Operating cash flow: -1396000
Depreciation & amortization: 30810000
Net tangible assets: 229555000
Owner earnings: 6077000
Return on net tangible assets (%): 2.6472958550238506
Capex to operating income (%): 433.91108971272666
Buffett classification: The Gruesome
Stock price: 6.65
P/E ratio: 99.97475787760416
Shares outstanding: 34637871
Book value: 227197000
P/B ratio: 1.01384191758694
Market cap (USD): 230341842.15
Debt to equity: 0.8797871450767396
Current ratio: 1.8736898160670814
Quick ratio: 0.5441067081417366
Effective tax rate (%): 23.96750169262018
Interest coverage ratio: 1.705721324938407
COGS to revenue (%): 47.431299526868685
SG&A to revenue (%): 51.61493754084986
Free cash flow (dilution-adjusted): -31172000
Buyback yield (%): 0
Retained earnings: 133172000
Inventory turnover: 1.9700054038589911
Receivables turnover: 108.145505710975
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.5229133569595503
FCF margin (%): -4.771416807106001
Rule of 40 score: -4.771416807106001
Financial ratios for DLTH — annual report dated 2024-01-31
Total revenue: 646681000
Gross profit: 324971000
Operating income: -9569000
Net income: -9923000
Capital expenditures: 49070000
Operating cash flow: 38673000
Depreciation & amortization: 32159000
Net tangible assets: 221968000
Owner earnings: -26834000
Return on net tangible assets (%): -12.089129964679593
Buffett classification: The Gruesome
Stock price: 4.88
Shares outstanding: 34637871
Book value: 219750000
P/B ratio: 0.7692050533788396
Market cap (USD): 169032810.48
Debt to equity: 0.8474493742889647
Current ratio: 1.7132822114929471
Quick ratio: 0.4964404051879201
Interest coverage ratio: -2.302454282964389
COGS to revenue (%): 49.747866413270216
SG&A to revenue (%): 51.73184305708688
Free cash flow (dilution-adjusted): -14608000
Buyback yield (%): 0
Retained earnings: 121392000
Inventory turnover: 2.5028980433345005
Receivables turnover: 98.39942178940962
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.4817158566315682
FCF margin (%): -2.2589190033416786
Revenue growth (%): -1.0142245529284089
Rule of 40 score: -3.2731435562700875
Financial ratios for DLTH — quarterly report dated 2024-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.7
Shares outstanding: 34637871
Market cap (USD): 128160122.7
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DLTH — quarterly report dated 2025-01-31
Total revenue: 241270000
Gross profit: 106479000
Operating income: -1413000
Net income: -3490000
Capital expenditures: 2516000
Operating cash flow: 41208000
Depreciation & amortization: 7552000
Net tangible assets: 182262000
Owner earnings: 1546000
Buffett classification: The Gruesome
Stock price: 2.92
Shares outstanding: 34637871
Book value: 179679000
P/B ratio: 0.56290709164677
Market cap (USD): 101142583.32
Debt to equity: 0.9079079914736836
Current ratio: 1.4897035845052358
Quick ratio: 0.17712633223722568
Interest coverage ratio: -1.0688350983358548
COGS to revenue (%): 55.867285613627885
SG&A to revenue (%): 44.71836531686492
Free cash flow (dilution-adjusted): 37998000
Buyback yield (%): 0
Retained earnings: 77721000
Inventory turnover: 0.7983073333096431
Receivables turnover: 60.77329974811083
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.43637374345671004
FCF margin (%): 15.749160691341652
Rule of 40 score: 15.749160691341652
Financial ratios for DLTH — annual report dated 2025-01-31
Total revenue: 626629000
Gross profit: 308510000
Operating income: -29113000
Net income: -43612000
Capital expenditures: 8329000
Operating cash flow: -16917000
Depreciation & amortization: 32282000
Net tangible assets: 182262000
Owner earnings: -19659000
Return on net tangible assets (%): -10.78612107844751
Buffett classification: The Gruesome
Stock price: 2.92
Shares outstanding: 34637871
Book value: 179679000
P/B ratio: 0.56290709164677
Market cap (USD): 101142583.32
Debt to equity: 0.9079079914736836
Current ratio: 1.4897035845052358
Quick ratio: 0.17712633223722568
Interest coverage ratio: -6.392841458058849
COGS to revenue (%): 50.766721616778035
SG&A to revenue (%): 53.879249125080385
Free cash flow (dilution-adjusted): -29292000
Buyback yield (%): 0
Retained earnings: 77721000
Inventory turnover: 1.8840777987041446
Receivables turnover: 157.84105793450883
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -8.990905019996603
FCF margin (%): -4.6745362886173485
Revenue growth (%): -3.10075601417082
Rule of 40 score: -7.775292302788168
Financial ratios for DLTH — quarterly report dated 2025-04-30
Total revenue: 102704000
Gross profit: 53355000
Operating income: -11803000
Net income: -15264000
Capital expenditures: 1332000
Operating cash flow: -56463000
Depreciation & amortization: 6749000
Net tangible assets: 167451000
Owner earnings: -9847000
Return on net tangible assets (%): -5.880526243498098
Buffett classification: The Gruesome
Stock price: 1.74
Shares outstanding: 34637871
Book value: 164893000
P/B ratio: 0.36550912130897006
Market cap (USD): 60269895.54
Debt to equity: 1.3578077905065709
Current ratio: 1.345132968895345
Quick ratio: 0.21204301897371206
Interest coverage ratio: -7.969615124915598
COGS to revenue (%): 48.04973516124007
SG&A to revenue (%): 63.44251441034429
Free cash flow (dilution-adjusted): -58049000
Buyback yield (%): 0
Retained earnings: 62428000
Inventory turnover: 0.27748632220554087
Receivables turnover: 24.17702448210923
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.8477462176162422
FCF margin (%): -56.52068079140054
Revenue growth (%): -57.4319227421561
Rule of 40 score: -113.95260353355664
Financial ratios for DLTH — quarterly report dated 2025-07-31
Total revenue: 131716000
Gross profit: 72019000
Operating income: 3252000
Net income: 1293000
Capital expenditures: 2240000
Operating cash flow: 32027000
Depreciation & amortization: 6545000
Net tangible assets: 169588000
Owner earnings: 5598000
Return on net tangible assets (%): 3.300941104323419
Capex to operating income (%): 68.88068880688807
Buffett classification: The Good
Stock price: 2.1
P/E ratio: 14.064100754060325
Shares outstanding: 34637871
Book value: 167058000
P/B ratio: 0.4354148206012283
Market cap (USD): 72739529.10000001
Debt to equity: 1.1310383220198972
Current ratio: 1.4407748934521503
Quick ratio: 0.278860906625339
Effective tax rate (%): -51.93889541715628
Interest coverage ratio: 2.2137508509189927
COGS to revenue (%): 45.3225120714264
SG&A to revenue (%): 52.20853958516809
Free cash flow (dilution-adjusted): 28693000
Buyback yield (%): 0
Retained earnings: 63689000
Inventory turnover: 0.3981259795258261
Receivables turnover: 14.622113676731795
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.067104183757178
FCF margin (%): 21.783989796228248
Revenue growth (%): 28.24816949680636
Rule of 40 score: 50.03215929303461
Financial ratios for DLTH — quarterly report dated 2025-10-31
Total revenue: 114871000
Gross profit: 61846000
Operating income: -8834000
Net income: -10067000
Capital expenditures: 2262000
Operating cash flow: -6679000
Depreciation & amortization: 6234000
Net tangible assets: 160185000
Owner earnings: -6095000
Return on net tangible assets (%): -3.8049754970814997
Buffett classification: The Gruesome
Stock price: 2.75
Shares outstanding: 34637871
Book value: 157684000
P/B ratio: 0.6040825020293752
Market cap (USD): 95254145.25
Debt to equity: 1.2446982572740417
Current ratio: 1.2874405515688758
Quick ratio: 0.1962178134233854
Interest coverage ratio: -7.176279447603575
COGS to revenue (%): 46.16047566400571
SG&A to revenue (%): 61.52989005057847
Free cash flow (dilution-adjusted): -9490000
Buyback yield (%): 0
Retained earnings: 53588000
Inventory turnover: 0.27348968192157125
Receivables turnover: 21.2134810710988
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.042733982936717
FCF margin (%): -8.26144109479329
Revenue growth (%): -12.788879103525769
Rule of 40 score: -21.050320198319056
Financial ratios for DLTH — annual report dated 2026-01-31
Total revenue: 565184000
Gross profit: 301614000
Operating income: -8932000
Net income: -16249000
Capital expenditures: 7600000
Operating cash flow: 24172000
Depreciation & amortization: 25471000
Net tangible assets: 168576000
Owner earnings: 1622000
Buffett classification: The Gruesome
Stock price: 2.41
Shares outstanding: 34637871
Book value: 166115000
P/B ratio: 0.5025269789603588
Market cap (USD): 83477269.11
Debt to equity: 0.8875477831622671
Current ratio: 1.5894297301541844
Quick ratio: 0.35741406228348127
Interest coverage ratio: -1.717031910803537
COGS to revenue (%): 46.63437039972823
SG&A to revenue (%): 54.94599988676254
Free cash flow (dilution-adjusted): 14066000
Buyback yield (%): 0
Retained earnings: 61332000
Inventory turnover: 1.9763500847317828
Receivables turnover: 208.5549815498155
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.0343590544975236
FCF margin (%): 2.4887470275167027
Revenue growth (%): -9.80564257319722
Rule of 40 score: -7.316895545680517
Financial ratios for DLTH — quarterly report dated 2026-01-31
Total revenue: 215893000
Gross profit: 114394000
Operating income: 9002000
Net income: 7789000
Capital expenditures: 1766000
Operating cash flow: 55287000
Depreciation & amortization: 5943000
Net tangible assets: 168576000
Owner earnings: 11966000
Return on net tangible assets (%): 7.098282080485953
Capex to operating income (%): 19.617862697178403
Buffett classification: The Great
Stock price: 2.41
P/E ratio: 2.679332042303248
Shares outstanding: 34637871
Book value: 166115000
P/B ratio: 0.5025269789603588
Market cap (USD): 83477269.11
Debt to equity: 0.8875477831622671
Current ratio: 1.5894297301541844
Quick ratio: 0.35741406228348127
Effective tax rate (%): 4.382519027743678
Interest coverage ratio: 8.816846229187071
COGS to revenue (%): 47.013566905828355
SG&A to revenue (%): 48.81677497649298
Free cash flow (dilution-adjusted): 52912000
Buyback yield (%): 0
Retained earnings: 61332000
Inventory turnover: 0.7610788680433707
Receivables turnover: 79.66531365313654
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.0581392978713287
FCF margin (%): 24.50843704983487
Revenue growth (%): 87.94386746872578
Rule of 40 score: 112.45230451856065
Financial ratios for DSRT.OL — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.068415051311288
Shares outstanding: 121027472
Market cap (USD): 492389988.70695555
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DSRT.OL — annual report dated 2022-12-31
Total revenue: 134412.95546558703
Gross profit: 28238.866396761132
Operating income: -6722672.064777328
Net income: -9155769.23076923
Capital expenditures: 1323785.4251012146
Operating cash flow: -8952935.222672064
Depreciation & amortization: 618218.6234817813
Net tangible assets: 10099089.06882591
Owner earnings: -9861336.032388663
Return on net tangible assets (%): -97.64579721183816
Buffett classification: The Gruesome
Stock price: 1.3856275303643724
Shares outstanding: 121027472
Book value: 10829959.51417004
P/B ratio: 15.484729828785046
Market cap (USD): 167698997.13360322
Debt to equity: 0.013869158878504673
Current ratio: 7.548117508019585
Quick ratio: 7.498733749788959
Interest coverage ratio: -16605
COGS to revenue (%): 78.9909638554217
R&D to revenue (%): 352.48493975903614
SG&A to revenue (%): 386.8222891566265
Free cash flow (dilution-adjusted): -10800303.643724697
Buyback yield (%): 0
Retained earnings: -12846052.631578946
Inventory turnover: 1.7931623931623935
Receivables turnover: 0.8447837150127226
Capitalized R&D asset: 473785.42510121455
ROCI (R&D-adjusted, %): -56.46331926938847
FCF margin (%): -8035.165662650605
Rule of 40 score: -8035.165662650605
Financial ratios for DSRT.OL — annual report dated 2023-12-31
Total revenue: 136247.5442043222
Gross profit: 130157.17092337918
Operating income: -6306581.532416503
Net income: -6411984.282907662
Capital expenditures: 1036935.1669941061
Operating cash flow: -4932612.966601179
Depreciation & amortization: 637721.0216110019
Net tangible assets: 12678487.229862476
Owner earnings: -6811198.428290766
Return on net tangible assets (%): -53.722485220854274
Buffett classification: The Gruesome
Stock price: 0.8015717092337918
Shares outstanding: 121027472
Book value: 12678487.229862476
P/B ratio: 7.651717104449627
Market cap (USD): 97012197.59528488
Debt to equity: 0.00359503203762387
Current ratio: 28.109262589928058
Quick ratio: 28.060476618705035
Interest coverage ratio: -1605.0249999999999
COGS to revenue (%): 4.470079307858688
R&D to revenue (%): 121.19682768565248
SG&A to revenue (%): 553.1362653208363
Free cash flow (dilution-adjusted): -5414931.237721022
Buyback yield (%): 0
Retained earnings: -18879567.779960707
Inventory turnover: 0.28571428571428575
Receivables turnover: 81.58823529411765
Capitalized R&D asset: 482563.9361930594
ROCI (R&D-adjusted, %): -48.28240709435082
Rosenberg metric: 0.21511490038944378
FCF margin (%): -3974.3330930064885
Revenue growth (%): 1.3648898146614166
Rule of 40 score: -3972.968203191827
Financial ratios for DSRT.OL — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.6908396946564885
Shares outstanding: 121027472
Market cap (USD): 83610581.80152671
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DSRT.OL — annual report dated 2024-12-31
Total revenue: 191703.44218887907
Gross profit: 167872.9037952339
Operating income: -5540688.437775817
Net income: -4840688.437775817
Capital expenditures: 6619.5939982347745
Operating cash flow: -4294174.757281553
Depreciation & amortization: 452691.9682259488
Net tangible assets: 6599293.909973522
Owner earnings: -4394616.063548103
Return on net tangible assets (%): -66.5922161294637
Buffett classification: The Gruesome
Stock price: 0.4673721340388007
Shares outstanding: 121027472
Book value: 6599293.909973522
P/B ratio: 8.571351516936476
Market cap (USD): 56564867.865961194
Debt to equity: 0
Current ratio: 10.535226077812828
Quick ratio: 10.512392969806218
Interest coverage ratio: -5231.333333333333
COGS to revenue (%): 12.430939226519339
R&D to revenue (%): 244.01473296500922
SG&A to revenue (%): 520.8563535911602
Free cash flow (dilution-adjusted): -5644924.9779346865
Buyback yield (%): 0
Retained earnings: -4840688.437775817
Inventory turnover: 1.7763157894736843
Receivables turnover: 5.776595744680851
Capitalized R&D asset: 734769.3927467394
ROCI (R&D-adjusted, %): -74.19991233682842
Rosenberg metric: 0.22840342690986382
FCF margin (%): -2944.6132596685084
Revenue growth (%): 40.70231012853559
Rule of 40 score: -2903.910949539973
Financial ratios for DSRT.OL — quarterly report dated 2024-12-31
Total revenue: 19417.47572815534
Gross profit: 18181.81818181818
Operating income: -1186672.5507502207
Net income: -624007.0609002648
Capital expenditures: 0
Operating cash flow: -601676.9638128862
Depreciation & amortization: 113945.27802294792
Net tangible assets: 6599293.909973522
Owner earnings: -510061.7828773168
Return on net tangible assets (%): -7.72903570950916
Buffett classification: The Gruesome
Stock price: 0.4673721340388007
Shares outstanding: 121027472
Book value: 6599293.909973522
P/B ratio: 8.571351516936476
Market cap (USD): 56564867.865961194
Debt to equity: 0
Current ratio: 10.535226077812828
Quick ratio: 10.512392969806218
Interest coverage ratio: -480.17857142857144
COGS to revenue (%): 6.363636363636364
Free cash flow (dilution-adjusted): -1050044.130626655
Buyback yield (%): 0
Retained earnings: -4840688.437775817
Inventory turnover: 0.09210526315789475
Receivables turnover: 0.5851063829787234
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -17.98205138493226
FCF margin (%): -5407.727272727273
Rule of 40 score: -5407.727272727273
Financial ratios for DSRT.OL — quarterly report dated 2025-03-31
Total revenue: 151812.97709923662
Gross profit: 93416.03053435114
Operating income: -1551240.458015267
Net income: -2101049.6183206104
Capital expenditures: 0
Operating cash flow: -1720324.427480916
Depreciation & amortization: 115076.33587786258
Net tangible assets: 5595992.366412213
Owner earnings: -1985973.2824427478
Return on net tangible assets (%): -35.48920642499062
Buffett classification: The Gruesome
Stock price: 0.583969465648855
Shares outstanding: 121027472
Book value: 5595992.366412213
P/B ratio: 12.629814968454799
Market cap (USD): 70676348.15267175
Debt to equity: 0
Current ratio: 7.68778801843318
Quick ratio: 7.5993663594470044
Interest coverage ratio: -2.6464268272830864
COGS to revenue (%): 38.46637335009429
Free cash flow (dilution-adjusted): -2073568.7022900763
Buyback yield (%): 0
Retained earnings: -2101049.6183206104
Inventory turnover: 0.9967426710097721
Receivables turnover: 0.8660860097985845
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -27.720560652047883
FCF margin (%): -1365.8705216844753
Revenue growth (%): 681.8368320610685
Rule of 40 score: -684.0336896234068
Financial ratios for DSRT.OL — quarterly report dated 2025-06-30
Total revenue: 12711.022840119165
Gross profit: 5362.462760675273
Operating income: -1660278.0536246276
Net income: -1914895.7298907647
Capital expenditures: 0
Operating cash flow: -1801489.5729890764
Depreciation & amortization: 82919.56305858986
Net tangible assets: 4341112.214498511
Owner earnings: -1831976.1668321749
Return on net tangible assets (%): -42.20061763696672
Buffett classification: The Gruesome
Stock price: 0.6971201588877854
Shares outstanding: 121027472
Book value: 4341112.214498511
P/B ratio: 19.4352705808075
Market cap (USD): 84370690.510427
Debt to equity: 0
Current ratio: 6.225855642155201
Quick ratio: 6.181294476448661
Interest coverage ratio: -5.971071428571428
COGS to revenue (%): 57.8125
Free cash flow (dilution-adjusted): -1995332.6713008936
Buyback yield (%): 0
Retained earnings: -4101489.5729890764
Inventory turnover: 0.2813688212927757
Receivables turnover: 0.3137254901960784
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -38.24545350566167
FCF margin (%): -15697.65625
Revenue growth (%): -91.62718294378071
Rule of 40 score: -15789.283432943781
Financial ratios for DSRT.OL — quarterly report dated 2025-09-30
Total revenue: 6012.024048096192
Gross profit: 6012.024048096192
Operating income: -1975150.3006012023
Net income: -2074448.897795591
Capital expenditures: 0
Operating cash flow: -1385571.142284569
Depreciation & amortization: 191583.16633266534
Net tangible assets: 8823547.094188377
Owner earnings: -1882865.7314629257
Return on net tangible assets (%): -21.33910219284797
Buffett classification: The Gruesome
Stock price: 0.16032064128256512
Shares outstanding: 121027472
Book value: 8823547.094188375
P/B ratio: 2.1990251445053888
Market cap (USD): 19403201.923847694
Debt to equity: 0
Current ratio: 5.531999267890916
Quick ratio: 5.512293331706425
Interest coverage ratio: -19.870967741935484
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): -1734869.7394789578
Buyback yield (%): 0
Retained earnings: -6212925.851703406
Inventory turnover: 0
Receivables turnover: 0.12631578947368421
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -22.384991880443796
FCF margin (%): -28856.666666666668
Revenue growth (%): -52.70227955911824
Rule of 40 score: -28909.368946225786
Financial ratios for DTIL — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 222
Shares outstanding: 25802247
Market cap (USD): 5728098834
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DTIL — annual report dated 2022-12-31
Total revenue: 25098000
Operating income: -62308000
Net income: -111637000
Capital expenditures: 3319000
Operating cash flow: -45753000
Depreciation & amortization: 9004000
Net tangible assets: 59702000
Owner earnings: -105952000
Return on net tangible assets (%): -177.46809152122208
Buffett classification: The Gruesome
Stock price: 35.7
Shares outstanding: 25802247
Book value: 60433000
P/B ratio: 15.242338091771053
Market cap (USD): 921140217.9000001
Debt to equity: 0.41301937683053963
Current ratio: 3.337104451595602
Quick ratio: 3.337104451595602
Interest coverage ratio: -56.08280828082808
COGS to revenue (%): 0
R&D to revenue (%): 183.76763088692326
SG&A to revenue (%): 164.49119451749144
Free cash flow (dilution-adjusted): -68269000
Buyback yield (%): 0
Retained earnings: -428312000
Receivables turnover: 34.858333333333334
Capitalized R&D asset: 46122000
ROCI (R&D-adjusted, %): -14.049958375440175
FCF margin (%): -272.00972189019046
Rule of 40 score: -272.00972189019046